An article Novel Tetrahydroquinazolinamines as Selective Histamine 3 Receptor Antagonists for the Treatment of Obesity WOS:000467781700024 published article about H-3 RECEPTOR; NEURONAL HISTAMINE; H3 RECEPTOR; AGONIST; PROTEIN; SYSTEM; DISCOVERY; TARGET; 2-AMINOPYRIMIDINES; IDENTIFICATION in [Kumar, Ajeet; Yadav, Anubhav; Dogra, Shalini; Sona, Chandan; Umrao, Deepmala; Yadav, Prem N.] Cent Drug Res Inst, Pharmacol Div, Lucknow 226031, Uttar Pradesh, India; [Pasam, Venkata Reddy; Thakur, Ravi Kumar; Singh, Kartikey; Tripathi, Rama Pati] Cent Drug Res Inst, Med & Proc Chem Div, Lucknow 226031, Uttar Pradesh, India; [Singh, Maninder; Siddiq, Mohammad Imran] Cent Drug Res Inst, Mol & Struct Biol Div, Lucknow 226031, Uttar Pradesh, India; [Shukla, Mahendra; Jaiswal, Swati; Ahmad, Hafsa; Rashid, Mamunur; Singh, Sandeep K.; Wahajuddin, Muhammad; Dwivedi, Anil Kumar; Lal, Jawahar] Cent Drug Res Inst, Pharmaceut & Pharmacokinet Div, Lucknow 226031, Uttar Pradesh, India; [Shukla, Mahendra; Jaiswal, Swati; Ahmad, Hafsa; Rashid, Mamunur; Singh, Sandeep K.; Wahajuddin, Muhammad; Dwivedi, Anil Kumar; Lal, Jawahar] Cent Drug Res Inst, CSIR, Lucknow 226031, Uttar Pradesh, India; [Siddiq, Mohammad Imran; Tripathi, Rama Pati; Yadav, Prem N.] Acad Sci & Innovat Res AcSIR, New Delhi 110001, India; [Tripathi, Rama Pati] Natl Inst Pharmaceut Educ & Res Raebareli, New Transit Campus,Bijnor Rd, Lucknow 226002, Uttar Pradesh, India in 2019.0, Cited 85.0. The Name is 3-Pyridinecarboxaldehyde. Through research, I have a further understanding and discovery of 500-22-1. HPLC of Formula: C6H5NO
The histamine 3 receptor (H3R) is a presynaptic receptor, which modulates several neurotransmitters including histamine and various essential physiological processes, such as feeding, arousal, cognition, and pain. The H3R is considered as a drug target for the treatment of several central nervous system disorders. We have synthesized and identified a novel series of 4-aryl-6-methyl-5,6,7,8-tetrahydroquinazolinamines that act as selective H3R antagonists. Among all the synthesized compounds, in vitro and docking studies suggested that the 4-methoxy-phenyl-substituted tetrahydroquinazolinamine compound 4c has potent and selective H3R antagonist activity (IC50 < 0.04 mu M). Compound 4c did not exhibit any activity on the hERG ion channel and pan-assay interference compounds liability. Pharmacokinetic studies showed that 4c crosses the blood brain barrier, and in vivo studies demonstrated that 4c induces anorexia and weight loss in obese, but not in lean mice. These data reveal the therapeutic potential of 4c as an anti-obesity candidate drug via antagonizing the H3R. Welcome to talk about 500-22-1, If you have any questions, you can contact Kumar, A; Pasam, VR; Thakur, RK; Singh, M; Singh, K; Shukla, M; Yadav, A; Dogra, S; Sona, C; Umrao, D; Jaiswal, S; Ahmad, H; Rashid, M; Singh, SK; Wahajuddin, M; Dwivedi, AK; Siddiq, MI; Lal, J; Tripathi, RP; Yadav, PN or send Email.. HPLC of Formula: C6H5NO
Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem